Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,728,535 papers from all fields of science
Search
Sign In
Create Free Account
KH902 fusion protein
Known as:
conbercept
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Recombinant Fusion Proteins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection.
Xiao Zhang
,
Jie Wu
,
Chan Wu
,
A. Bian
,
S. Geng
,
R. Dai
Diabetes Research and Clinical Practice
2020
Corpus ID: 211114100
2020
2020
Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Shuang Gao
,
Zhongjing Lin
,
+4 authors
Xi Shen
Journal of Ocular Pharmacology and Therapeutics
2020
Corpus ID: 214583631
Purpose: To assess the clinical effects of preoperative, intraoperative, or preoperative combined with intraoperative…
Expand
Review
2020
Review
2020
Intravitreal conbercept improves outcome in patients undergoing vitrectomy for proliferative diabetic retinopathy: A systematic review and meta‐analysis
R. Pranata
,
Amelinda Vania
Journal of Evidence-Based Medicine
2020
Corpus ID: 212692136
To evaluate the latest evidence concerning the efficacy of conbercept on vitrectomy for proliferative diabetic retinopathy (PDR…
Expand
2020
2020
Comparison of the Efficacy of Three Loading Doses of Intravitreal Injection of Conbercept with Injection Combined with PDT for the Treatment of PCV
Fengjiao Li
,
Aihua Ma
,
Bojun Zhao
BioMed Research International
2020
Corpus ID: 218555767
Purpose To compare the efficacy between initial 3-monthly intravitreal conbercept monotherapy and combination intravitreal…
Expand
2019
2019
Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy.
Qianyi Lu
,
Li Lu
,
Bin Chen
,
Wei Chen
,
P. Lu
Canadian Journal of Ophthalmology-journal…
2019
Corpus ID: 81913560
2019
2019
Comment on Ethical Concerns Regarding Conbercept for Treatment of Neovascular Age-Related Macular Degeneration: Phase 3 PHOENIX Study.
A. Grzybowski
,
P. Kanclerz
American journal of ophthalmology-glaucoma
2019
Corpus ID: 207944602
2018
2018
Observation of curative effect of intravitreal injection of conbercept in wet age‐related macular degeneration: Optical coherence tomography analysis after injection
Wen Yang
,
Ying-jun Tan
,
Chao-peng Li
,
Y. Liu
,
Guohua Lu
Microscopy research and technique (Print)
2018
Corpus ID: 4445786
To observe the clinical efficacy of intravitreal injection of conbercept in the treatment of wet age‐related macular degeneration…
Expand
2017
2017
Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategies.
G. Qiao
,
W. Dong
,
Yan Dai
,
Zhenxuan Jiang
,
Haike Guo
International Journal of Ophthalmology
2017
Corpus ID: 23333385
AIM To appraise the effect of treatment for diabetic macular edema (DME) in proliferative stage with sufficient panrentinal…
Expand
2017
2017
A safety study of high concentration and high frequency intravitreal injection of conbercept in rabbits
Jiaming Wang
,
C. Lei
,
+4 authors
B. Lei
Scientific Reports
2017
Corpus ID: 4226698
The novel anti-VEGF drug conbercept has been used in the treatment of several retinal neovascular diseases. Owning to the…
Expand
2016
2016
Correlation of Vascular Endothelial Growth Factor Production with Photochemical Reaction-induced Retinal Edema
L. Shan
,
Mi Zheng
,
+5 authors
Xin Xia
Chinese Medical Journal
2016
Corpus ID: 14783544
Background:Retinal edema is the major complication of retinal vein occlusion and diabetic retinopathy; it can damage visual…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE